Innovating Works

LAMINAR PHARMACEUTICALS

Activa
PANC561: LAM561 BEATS PANCREATIC CANCER LAMINAR PHARMACEUTICALS tramitó un H2020: H2020-MSCA-IF-2020 Pancreatic cancer is a highly aggressive type of cancer, with poor prognosis and few effective therapeutic options. At the time of diagnosis...
2021-03-09 - 2023-03-31 | Financiado
YesElf: We help employees to adopt digital solutions BRAINWARE S.R.O tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Only in EU, about 26 million active companies employing about 144 million employees invest billions of euros per year in onboarding process...
2019-07-11 - 2020-01-31 | Financiado
CLINGLIO: A Clinical Phase IIB trial with 2OHOA in patients with newly diagnosed malignant glioma. LAMINAR PHARMACEUTICALS tramitó un H2020: H2020-SC1-2016-2017 "Glioma is a rare brain cancer with one of the highest mortality rates. It is considered an orphan disease due to its low prevalence (less t...
2017-11-27 - 2022-05-31 | Financiado
GRAPHIL: Exploring the Interface Between Ionic Liquids and Graphene Elucidating Structure and Electronic Pr... KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un H2020: H2020-MSCA-IF-2015 GRAPHIL aims at generating a detailed picture of the lateral nanostructure of the ionic liquid (IL)-graphene interface. A special focus will...
2016-02-15 - 2018-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.